Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-26T17:48:45.258Z Has data issue: false hasContentIssue false
  • English
  • Français

Nasal decongestant effect of oxymetazoline in the common cold: An objective dose-response study in 106 patients

Published online by Cambridge University Press:  29 June 2007

Anders Åkerland ,
Thorsten Klint ,
Lars Olén  and
Hans Rundcrantz
Anders Åkerland
Affiliation:
From the Department of Otorinolaryngology, Central Hospital, Sköevde
Thorsten Klint
Affiliation:
Department of Clinical Research, AB Draco, Lund, Sweden
Lars Olén
Affiliation:
From the Department of Otorinolaryngology, Central Hospital, Sköevde
Hans Rundcrantz*
Affiliation:
From the Department of Otorinolaryngology, Central Hospital, Sköevde
*
Dr. Hans Rundcrantz, M.D., PhD. Department of Otorhinolaryngology, Central Hospital, S-541 85 Skoevde, Sweden.
Get access Rights & Permissions [Opens in a new window]

Abstract

Oxymetazoline has been used as decongesting nosedrops for more than 25 years but so far no objective does-response study of the drug has been published. In this double-blind clinical trial the decongestant effect on the nasal mucosa by the doses and concentrations traditionally used of oxymetazoline were studied.

In 106 men with acute infectious rhinitis, a significant dose-response relationship was found when the decongestant effect was measured objectively by anterior rhinomanometry and subjectively by symptom scores.

The concentration and volumes of the drug recommended from clinical experience seem to be adequate.

Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 103 , Issue 8 , August 1989 , pp. 743 - 746
Copyright
Copyright © JLO (1984) Limited 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Andersson, K. -E. and Bende, M. (1984) Adrenoceptors in the control of human nasal mucosal blood flow. Annals Otology, Rhinology and Laryngology, 93: 179–182.CrossRefGoogle ScholarPubMed
Bende, M. (1983) The efford of topical decongestant on blood flow in normal and infected nasal mucosa. Acta Otolaryngologica, 96: 523–27.CrossRefGoogle Scholar
Bende, M. and Löth, S. (1986) Vascular effects of topical oxymetazoline on human nasal mucosa. Journal of Laryngology and Otology, 100: 285–288.CrossRefGoogle ScholarPubMed
Bende, M., Anderson, K. E., Johansson, C. J., Sjögren, C. and Svensson, G. (1984) Dose-response relationship of a topical nasal decongestant: Phenylpropanolamine. Acta Otolaryngologica, 98: 543–544.CrossRefGoogle ScholarPubMed
Broms, P., Jonsson, B. and Lamm, C. J. (1982) Rhinomanometry. A system for numerical description of the nasal airway resistance. Acta Otolaryngologica, 94: 157–168.CrossRefGoogle ScholarPubMed
Connell, J. (1969) Effectiveness of topical nasal decongestants. Annals of Allergy 27: 541–546.Google Scholar
Knothe, J. and Rietschel, M. (1976) Vergleichende Untersuchungen zum therapeutischen Effekt verschidener Antrhinitika. Das Deutsche Gesundheitswesen, 31: 569–573.Google Scholar
Petruson, B. (1981) Treatment with xylometazoline (Otrivine) nosedrops over a six-weeks period. Rhinology 19: 167–172.Google Scholar
Petruson, B. and Hansson, H.-A. (1982) Function and structure of the nasal mucosa after 6 weeks use of nose-drops. Acta Otolaryngologica, 94: 563–569.CrossRefGoogle ScholarPubMed